Folgen
Timo Z. Nazari Shafti
Timo Z. Nazari Shafti
Postdoctoral Fellow, German Heart Centre Berlin
Bestätigte E-Mail-Adresse bei dhzb.de
Titel
Zitiert von
Zitiert von
Jahr
Proton pump inhibitors accelerate endothelial senescence
G Yepuri, R Sukhovershin, TZ Nazari-Shafti, M Petrascheck, YT Ghebre, ...
Circulation research 118 (12), e36-e42, 2016
1452016
Minimally invasive surgical mitral valve repair: state of the art review
KM Van Praet, C Stamm, SH Sündermann, A Meyer, A Unbehaun, ...
Interventional Cardiology Review 13 (1), 14, 2018
942018
Prospective dual role of mesenchymal stem cells in breast tumor microenvironment
C Senst, T Nazari-Shafti, S Kruger, KHZ Bentrup, CL Dupin, AE Chaffin, ...
Breast cancer research and treatment 137, 69-79, 2013
612013
No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit: a Swedish nationwide registry study
M Janiec, A Dimberg, TZ Nazari Shafti, B Lagerqvist, RPF Lindblom
European Journal of Cardio-Thoracic Surgery 53 (2), 448-454, 2018
342018
Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection
TZ Nazari-Shafti, E Freisinger, U Roy, CT Bulot, C Senst, CL Dupin, ...
Retrovirology 8, 1-12, 2011
342011
Mechanical fingerprint of senescence in endothelial cells
N Chala, S Moimas, C Giampietro, X Zhang, T Zambelli, V Exarchos, ...
Nano Letters 21 (12), 4911-4920, 2021
332021
Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease
TZ Nazari-Shafti, S Neuber, A Garcia Duran, Z Xu, E Beltsios, M Seifert, ...
Stem Cells Translational Medicine 9 (12), 1558-1569, 2020
302020
Telomerase therapy to reverse cardiovascular senescence
TZ Nazari-Shafti, JP Cooke
Methodist DeBakey cardiovascular journal 11 (3), 172, 2015
272015
Graft failure and recurrence of symptoms after coronary artery bypass grafting
M Janiec, TZ Nazari Shafti, A Dimberg, B Lagerqvist, RPF Lindblom
Scandinavian Cardiovascular Journal 52 (3), 113-119, 2018
252018
An overview of surgical treatment modalities and emerging transcatheter interventions in the management of tricuspid valve regurgitation
KM Van Praet, C Stamm, CT Starck, S Sündermann, A Meyer, ...
Expert Review of Cardiovascular Therapy 16 (2), 75-89, 2018
252018
Impact of thyroidectomy on cardiac manifestations of G raves' disease
JM Gauthier, HE Mohamed, SI Noureldine, TZ Nazari‐Shafti, TK Thethi, ...
The Laryngoscope 126 (5), 1256-1259, 2016
222016
Minimally invasive coronary revascularisation surgery: a focused review of the available literature
KM Van Praet, M Kofler, TZN Shafti, A Abd, A van Kampen, A Amabile, ...
Interventional Cardiology Review 16, 2021
202021
Mitral valve surgery: current status and future prospects of the minimally invasive approach
KM Van Praet, J Kempfert, S Jacobs, C Stamm, S Akansel, M Kofler, ...
Expert Review of Medical Devices 18 (3), 245-260, 2021
192021
Exosomes for cardioprotection: are we ready for clinical translation?
TZ Nazari-Shafti, C Stamm, V Falk, MY Emmert
European Heart Journal 40 (12), 953-956, 2019
182019
MiRNA profiles of extracellular vesicles secreted by mesenchymal stromal cells—Can they predict potential off-target effects?
TZ Nazari-Shafti, S Neuber, AG Duran, V Exarchos, CM Beez, H Meyborg, ...
Biomolecules 10 (9), 1353, 2020
172020
High yield recovery of equine mesenchymal stem cells from umbilical cord matrix/Wharton’s jelly using a semi-automated process
TZ Nazari-Shafti, IG Bruno, RF Martinez, ME Coleman, EU Alt, ...
Stem Cell Protocols, 131-146, 2015
132015
MicroRNA Mediated Cardioprotection–Is There a Path to Clinical Translation?
TZ Nazari-Shafti, V Exarchos, HRC Biefer, N Cesarovic, H Meyborg, ...
Frontiers in Bioengineering and Biotechnology 8, 149, 2020
122020
Toward next-generation advanced therapies: extracellular vesicles and cell therapy–partners or competitors?
TZ Nazari-Shafti, S Neuber, V Falk, MY Emmert
Regenerative medicine 16 (03), 215-218, 2021
92021
Minimally invasive cardiac surgery: removal of an interatrial intraseptal bronchogenic cyst through a periareolar approach
KM Van Praet, C Stamm, SH Sündermann, A Meyer, A Unbehaun, ...
Innovations 13 (3), 230-232, 2018
92018
Limiting transactivator amounts contribute to transgene mosaicism in Tet-on all-in-one systems
AG Duran, M Schwestka, TZ Nazari-Shafti, S Neuber, C Stamm, ...
ACS Synthetic Biology 11 (8), 2623-2635, 2022
62022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20